Screening for diabetic retinopathy with a non-mydriatic fundus camera using artificial intelligence software

Czech version

Authors: Linda Ilavská ^1,3; Alexandra Bražinová ²
Authors‘ workplace: Lekárska fakulta UK v Bratislave (odbor Všeobecné lekárstvo, poslucháčka 4. ročníka) ¹; Ústav epidemiológie LF UK v Bratislave ²; Diabetologická a metabolická ambulancia Medispektrum s. r. o., Bratislava ³
Published in: Diab Obez 2024; 24(48): 131-136
Category: Reviews

Overview

This study evaluates AI-based technology in screening for diabetic retinopathy among patients with type 1, type 2, gestational, and specific diabetes types. Using the non-mydriatic DRSplus^® camera and RetCAD™ software, we analyzed color fundus images in 403 adults from January to March 2024. Diabetic retinopathy was found in 55.6% of type 1 and 31.8% of type 2 patients. No retinopathy was detected in gestational or specific diabetes cases. Our findings suggest that AI technology is a promising tool for effective diabetic retinopathy screening and early diagnosis.

Keywords:

artificial intelligence – Diabetic retinopathy – diabetes mellitus – screening for complication

Sources

Promoting diabetic retinopathy screening. WHO 2024. [cit. 2. 4. 2024]. Dostupné z WWW: <https://www.who.int/europe/activities/promoting-diabetic-retinopathy-screening>.

Klein R, Knudtson MD, Lee KE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008; 115(11): 1859–1868. Dostupné z DOI: <https://doi: 10.1016/j.ophtha.2008.08.023>. PMID: 19068374; PMCID: PMC2761813.

Štefaničková J. Diabetická retinopatia. Publikované: 2. 4. 2020. [cit. 2. 4. 2024]. Dostupné z WWW: <https://portal.fmed.uniba.sk/ clanky.php?aid=417>.

Mišuth J, Štefaničková J, Tkáč I et al. Analýza vyšetrovaného očného pozadia u pacientov s ochorením diabetes mellitus na základe dát zdravotnej poisťovne. Oftalmol Prax 2024; 3(1): 41–46.

iCare DRSplus TrueColor confocal fundus imaging systém. Icare Finland Oy . [cit. 2. 4. 2024]. Dostupné z WWW: <https://www.icare-world.com/product/icare-drsplus>.

Fast and reliable screening of big populations for eye disease symptoms. Thirona Retina. [cit. 2. 4. 2024]. Dostupné z WWW: <https://retcad.eu/large-scale-screening-programs-use-case>.

Diabetic retinopathy grading. The University of Melbourne 2023. [cit. 2. 4. 2024]. Dostupné z WWW: <https://drgrading.iehu.unimelb.edu.au/cera/index.asp>.

Činnosť diabetologických ambulancií v Slovenskej republike 2022. NCZI 2023 . [cit. 5.4.2024]. Dostupné z WWW: <https://www.nczisk.sk/Aktuality/Pages/Cinnost-diabetologickych-ambulancii-v-Slovenskej-republike-v-roku-2022.aspx>.